Literature DB >> 17496910

Integrating signals from RTKs to ERK/MAPK.

M M McKay1, D K Morrison.   

Abstract

Signals received at the cell surface must be properly transmitted to critical targets within the cell to achieve the appropriate biological response. This process of signal transduction is often initiated by receptor tyrosine kinases (RTKs), which function as entry points for many extracellular cues and play a critical role in recruiting the intracellular signaling cascades that orchestrate a particular response. Essential for most RTK-mediated signaling is the engagement and activation of the mitogen-activated protein kinase (MAPK) cascade comprised of the Raf, MEK and extracellular signal-regulated kinase (ERK) kinases. For many years, it was thought that signaling from RTKs to ERK occurred only at the plasma membrane and was mediated by a simple, linear Ras-dependent pathway. However, the limitation of this model became apparent with the discovery that Ras and ERK can be activated at various intracellular compartments, and that RTKs can modulate Ras/ERK signaling from these sites. Moreover, ERK scaffolding proteins and signaling modulators have been identified that play critical roles in determining the strength, duration and location of RTK-mediated ERK signaling. Together, these factors contribute to the diversity of biological responses generated by RTK signaling.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17496910     DOI: 10.1038/sj.onc.1210394

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  248 in total

1.  Alternative splicing of Bim and Erk-mediated Bim(EL) phosphorylation are dispensable for hematopoietic homeostasis in vivo.

Authors:  C Clybouw; D Merino; T Nebl; F Masson; M Robati; L O'Reilly; A Hübner; R J Davis; A Strasser; P Bouillet
Journal:  Cell Death Differ       Date:  2012-01-13       Impact factor: 15.828

Review 2.  The role of agrin in synaptic development, plasticity and signaling in the central nervous system.

Authors:  Mathew P Daniels
Journal:  Neurochem Int       Date:  2012-03-05       Impact factor: 3.921

3.  VRK2 anchors KSR1-MEK1 to endoplasmic reticulum forming a macromolecular complex that compartmentalizes MAPK signaling.

Authors:  Isabel F Fernández; Luis G Pérez-Rivas; Sandra Blanco; Adrián A Castillo-Dominguez; José Lozano; Pedro A Lazo
Journal:  Cell Mol Life Sci       Date:  2012-07-04       Impact factor: 9.261

Review 4.  Mechanistic principles of RAF kinase signaling.

Authors:  Christian M Udell; Thanashan Rajakulendran; Frank Sicheri; Marc Therrien
Journal:  Cell Mol Life Sci       Date:  2010-09-06       Impact factor: 9.261

Review 5.  Ras and Rap signaling in synaptic plasticity and mental disorders.

Authors:  Ruth L Stornetta; J Julius Zhu
Journal:  Neuroscientist       Date:  2010-04-29       Impact factor: 7.519

Review 6.  Mitogen-activated protein kinase signaling in the heart: angels versus demons in a heart-breaking tale.

Authors:  Beth A Rose; Thomas Force; Yibin Wang
Journal:  Physiol Rev       Date:  2010-10       Impact factor: 37.312

7.  Suppression of Ras/Mapk pathway signaling inhibits Myc-induced lymphomagenesis.

Authors:  M W Gramling; C M Eischen
Journal:  Cell Death Differ       Date:  2012-02-03       Impact factor: 15.828

Review 8.  Mucins and toll-like receptors: kith and kin in infection and cancer.

Authors:  Shikha Tarang; Sushil Kumar; Surinder K Batra
Journal:  Cancer Lett       Date:  2012-02-03       Impact factor: 8.679

Review 9.  Functional proteomics to dissect tyrosine kinase signalling pathways in cancer.

Authors:  Walter Kolch; Andrew Pitt
Journal:  Nat Rev Cancer       Date:  2010-08-19       Impact factor: 60.716

10.  The potential role of extracellular regulatory kinase in the survival of patients with early stage adenocarcinoma.

Authors:  Simone de Leon Martini; Carolina Beatriz Müller; Rosalva Thereza Meurer; Marilda da Cruz Fernandes; Rodrigo Mariano; Mariel Barbachan E Silva; Fábio Klamt; Cristiano Feijó Andrade
Journal:  J Thorac Dis       Date:  2014-07       Impact factor: 2.895

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.